SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001047469-20-001984
Filing Date
2020-04-01
Accepted
2020-04-01 16:16:53
Documents
10

Document Format Files

Seq Description Document Type Size
1 424B3 a2241237z424b3.htm 424B3 3599206
2 G963789.JPG g963789.jpg GRAPHIC 9715
3 G243821.JPG g243821.jpg GRAPHIC 9651
4 G869849.JPG g869849.jpg GRAPHIC 166401
5 G270201.JPG g270201.jpg GRAPHIC 64031
6 G819191.JPG g819191.jpg GRAPHIC 39372
7 G747769.JPG g747769.jpg GRAPHIC 87706
8 G597014.JPG g597014.jpg GRAPHIC 14168
9 G540257.JPG g540257.jpg GRAPHIC 11014
10 G397349.JPG g397349.jpg GRAPHIC 3720
  Complete submission text file 0001047469-20-001984.txt   4160406
Mailing Address 900 E. HAMILTON AVE. SUITE 100 CAMPBELL CA 95008
Business Address 900 E. HAMILTON AVE. SUITE 100 CAMPBELL CA 95008 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 424B3 | Act: 33 | File No.: 333-236526 | Film No.: 20765594
SIC: 2834 Pharmaceutical Preparations